sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group, Inc. Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has disclosed its position in Mural Oncology plc under Rule 8.3 of the Irish Takeover Panel Act, 1997. This pertains to securities representing more than 1% in relevant interests. The disclosure was made on 25 November 2025, with the position held as of 24 November 2025.
The Vanguard Group's relevant securities in Mural Oncology include $0.01 ordinary shares totaling 243,005, representing 1.41%. A recent transaction involved the sale of 46,206 $0.01 ordinary shares at a unit price of 2.09 USD.
No cash-settled or stock-settled derivatives were disclosed, nor were there any indemnity arrangements, agreements, or understandings involving options or derivatives. There was also no attachment of a Supplemental Form 8 to the disclosure.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.